Pharmacological doses of vitamin C are able to inhibit citrate synthase (CS) activity and reduce the level of glucose-derived citrate, which in turn inhibited tumor proliferation and significantly enhanced the response to gemcitabine. This evidence concerns the gene CS and neoplasm.